SOURCE: Elsevier Business Intelligence

Elsevier Business Intelligence

April 02, 2012 10:16 ET

Windhover Announces the Presenting Companies for the 9th Annual PSO Conference at the Grand Hyatt New York, April 11-13, 2012

BRIDGEWATER, NJ--(Marketwire - Apr 2, 2012) - Elsevier Business Intelligence and Windhover are proud to announce the carefully selected companies that will be presenting at the 9th Annual 2012 Pharmaceutical Strategic Outlook Conference at the Grand Hyatt New York, from April 11th to the 13th. These Top Biotech Companies to Watch have been handpicked by Windhover's elite selection panel to ensure a vigorous, high quality agenda, and will focus their presentations on the top issues in the industry affecting biopharma strategic dealmaking.

Attendees of the conference are encouraged to take advantage of this exciting new line-up of companies, promising not only the opportunity for cohesive learning and insight on the industry's latest trends, but also the potential in high-value assets for partnership as well as the distinctive possibility of creating future growth through investments in deals.

The list of presenting companies, in alphabetical order, is as follows:

  • Altheus
  • Anaptysbio Inc.
  • Aptalis Pharmaceutical Technologies
  • Axios Biosciences
  • Cerenis Therapeutics SA
  • Cytokinetics Inc.
  • Epizyme
  • Excelimmune, Inc.
  • GeoVax, Inc.
  • Idera Pharmaceuticals, Inc.
  • Liquidia
  • MolMed
  • Veloxis Pharmaceuticals

This all-star cast of presenting companies guarantees for a dynamic three days of networking and discussion where senior executives will gather to drive pipelines, profits and personal career growth through partnering and knowledge-building! For registration, more information, or to hear what past attendees are saying about PSO, visit

About Windhover Conferences and Elsevier Business
Intelligence Windhover Conferences is an Elsevier Business Intelligence company, the leading provider of business intelligence and analysis to senior executives in the medical device, pharmaceutical, and biotechnology industries. Publishers of The Pink Sheet, IN VIVO: The Business & Medicine Report, PharmAsia News, The Tan Sheet", Start-Up: Emerging Medical Ventures, and The RPM Report: Regulation • Policy • Market Access, Elsevier Business Intelligence and Windhover also host a variety of industry meetings and webinars in both medical device and pharma/biotech, and produce a wide array of market research reports. For more on the companies' products and services, please visit

About Elsevier
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include SciVerse ScienceDirect, SciVerse Scopus, Reaxys, MD Consult and Nursing Consult, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai's Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), (NYSE: RUK) and ENL (New York Stock Exchange).

Contact Information

    Michael Fergus
    Elsevier Business Intelligence
    Phone: (908) 547-2167
    Email: Email Contact